UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection
NCT04406727
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV-1 Infection
Interventions
BIOLOGICAL:
UB-421
OTHER:
Antiretroviral (ARV)
Sponsor
United BioPharma